Dr Reddy’s in final leg of pilot launch of SputnikV vaccine


Dr. Reddy’s Laboratories, which have a marketing agreement with RDIF for the Russian SputnikV vaccine in India, announced today that the limited pilot launch is in the final stages and is preparing for commercial launch of the vaccine.

In a statement on SputnikV in India, Dr. Reddy’s: “The limited pilot soft start of the SputnikV vaccine released on May 14th by Dr. Reddy’s was initiated in Hyderabad, has now been successful in other cities such as Visakhapatnam, Bengaluru, Mumbai, Kolkata, Delhi, Baddi, Chennai, Miryalaguda and Kolhapur, with more cities to follow in the next few days. “

“As this is currently a limited pilot phase, registration with CoWIN is not yet open to the public. This will open at the time of our commercial launch, ”it said.

“This pilot phase has enabled us to test our cold storage arrangements with a temperature of -18 degrees C in these cities, the CoWIN integration, track-and-trace and other logistical arrangements before our commercial introduction.”

“The limited pilot phase is currently in its final phase as we prepare to ensure a smooth commercial launch. A sufficient number of cold chain units are deployed and the cold chain control for the last mile is validated in each partner hospital to ensure smooth storage and handling of the vaccine. All necessary supply precautions are taken to ensure the availability of both dose components in the right amount and at the right time in the partner clinics. “

As soon as the pilot phase is completed, Dr. Reddy’s announce the commercial launch of Sputnik V.

“We will be releasing updates on the date of the commercial launch of the Sputnik-V vaccine in India, supply agreements and partnerships in different parts of the country,” it said in a statement.